Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Drug Metabolism and Pharmacokinetics|December 27, 2023
Quantification of fluticasone propionate in human plasma by LC-MS/MS and its application in the pharmacokinetic study of nasal spray at clinical dosesAya Yamagata, Rena Adachi, Akitomo Yokokawa, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 31, 2004
Simultaneous determination of 6beta-hydroxycortisol and cortisol in human urine by liquid chromatography with ultraviolet absorbance detection for phenotyping the CYP3A activity determined by the cortisol 6beta-hydroxylation clearanceTakashi Furuta, Chieko Mori, Atsushi Suzuki, et al.
British Journal of Clinical Pharmacology|May 1, 2026
Endogenous melatonin partial metabolic clearance as a potential endogenous marker of CYP1A2 activityAkitomo Yokokawa, Hayato Shimazaki, Shunji Igarashi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2003
Evidence for the validity of cortisol 6 beta-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotyping in humansTakashi Furuta, Atsushi Suzuki, Chieko Mori, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 10, 2009
Simultaneous determination of androstenedione, 11beta-hydroxyandrostenedione, and testosterone in human plasma by stable isotope dilution mass spectrometryAkitomo Yokokawa, Kazuhiro Yamamoto, Yuhei Omori, et al.
Chemical & Pharmaceutical Bulletin|May 1, 2022
Development and Validation of an LC-MS/MS-Based Method for Quantifying Urinary Endogenous 6-HydroxymelatoninSeiya Ohki, Miyu Kunimatsu, Shingo Ogawa, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 24, 2012
Intraindividual and interindividual variabilities in endogenous cortisol 6β-hydroxylation clearance as an index for in vivo CYP3A phenotyping in humansHiromi Shibasaki, Kaori Hosoda, Mari Goto, et al.
Pageof 3